BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18497964)

  • 1. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
    Yokoyama Y; Takano T; Nakahara K; Shoji T; Sato H; Yamada H; Yaegashi N; Okamura K; Kurachi H; Sugiyama T; Tanaka T; Sato A; Tase T; Mizunuma H
    Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
    Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
    Niibe Y; Hayakawa K; Tsunoda S; Kanai T; Imai M; Arai M; Arai T; Kawaguchi M; Jobo T; Hamada Y; Yago K; Unno N;
    Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
    J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T; Moromizato H; Ogawa K; Kakinohana Y; Maehama T; Kanazawa K; Murayama S
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
    Idei T; Sakamoto H; Nakajima Y; Hiraiwa Y; Takami N; Chishima F; Ohtani K; Nagaishi M; Yamamoto T; Kawamori J; Himi K; Tanaka Y
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):505-9. PubMed ID: 12722682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
    Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
    Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
    Yuan G; Wu L; Huang M; Li N; An J
    Radiat Oncol; 2014 Feb; 9():55. PubMed ID: 24533532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.